샘플 요청 목록

 카트 문의
시장보고서
상품코드
1650908

세계의 헤모글로빈 검사 시장

Hemoglobin Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 174 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헤모글로빈 검사 세계 시장 2030년까지 39억 달러에 달할 전망

2024년에 28억 달러로 추정되는 헤모글로빈 검사 세계 시장은 2024-2030년 동안 연평균 5.6%의 CAGR로 성장하여 2030년에는 39억 달러에 달할 것으로 예상됩니다. 헤모글로빈 검사 시약 및 소모품은 이 보고서에서 분석한 부문 중 하나이며, CAGR 5.8%를 기록하여 분석 기간 종료 시 30억 달러에 도달할 것으로 예상됩니다. 헤모글로빈 검사 장비 부문의 성장률은 분석 기간 동안 CAGR 4.9%로 추정됩니다.

미국 시장 7억 4,210만 달러로 추정, 중국은 CAGR 8.2%로 성장 전망

미국의 헤모글로빈 검사 시장은 2024년에 7억 4,210만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2024-2030년 분석 기간 동안 8.2%의 CAGR로 2030년까지 8억 8,570만 달러의 시장 규모에 도달할 것으로 예측됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.8%와 5.1%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.3%로 성장할 것으로 예상됩니다.

세계 헤모글로빈 검사 시장 - 주요 동향 및 촉진요인 정리

헤모글로빈 검사는 혈액 질환 진단의 핵심인가?

헤모글로빈 검사는 환자의 혈액 건강 상태와 전반적인 건강 상태에 대한 중요한 인사이트를 제공하며, 현대 의료에서 중요한 역할을 하고 있습니다. 그렇다면 왜 이 검사가 필수적인 것일까? 헤모글로빈은 적혈구에 포함된 단백질로 폐에서 전신으로 산소를 운반하는 역할을 합니다. 혈중 헤모글로빈 농도를 측정함으로써 의료진은 환자의 산소 운반 능력을 평가하고 빈혈, 출혈, 기타 기저 질환과 같은 잠재적인 건강 문제를 발견할 수 있습니다. 헤모글로빈 검사는 가장 일반적인 진단 도구 중 하나이며 정기 검진, 수술 전 평가, 만성질환 관리에 사용됩니다.

헤모글로빈 수치는 다양한 건강 상태를 나타내는 중요한 지표입니다. 헤모글로빈 수치가 낮으면 산소를 효율적으로 운반할 수 있는 건강한 적혈구가 체내에 충분하지 않은 상태인 빈혈을 나타내는 경우가 많습니다. 빈혈은 영양 부족(철분, 비타민 B12, 엽산 등)에서부터 신장 질환, 암과 같은 만성질환에 이르기까지 다양한 요인에 의해 유발될 수 있습니다. 반대로 헤모글로빈 수치가 높으면 다혈증이나 탈수 등의 상태를 나타낼 수 있습니다. 따라서 정기적인 헤모글로빈 검사는 특정 혈액 질환의 진단뿐만 아니라 전신 건강 상태를 모니터링하고 만성질환을 앓고 있는 사람의 치료 계획을 세우는 데에도 필수적입니다.

기술이 헤모글로빈 검사를 어떻게 변화시켰는가?

기술의 발전은 헤모글로빈 검사에 혁명을 가져왔고, 더 빠르고, 더 정확하고, 다양한 상황에서 이용할 수 있게 되었습니다. 가장 중요한 기술 혁신 중 하나는 POCT(Point of Care Testing) 장비의 개발로, 이를 통해 기존 검사실이 아닌 진료소나 가정에서도 헤모글로빈 수치를 측정할 수 있게 되었습니다. 이러한 휴대용 기기는 거의 즉각적인 결과를 제공하여 의료진이 신속한 진단 결정을 내릴 수 있도록 돕습니다. 이러한 실시간 데이터는 빈혈과 같은 질환을 관리하거나 화학요법이나 투석과 같은 치료 중 혈액 건강을 모니터링하는 데 특히 유용합니다.

자동 혈액 분석기는 헤모글로빈 검사의 또 다른 큰 발전입니다. 이 기기들은 헤모글로빈 농도를 포함한 여러 혈액 파라미터를 단 몇 분 만에 높은 정확도로 처리할 수 있습니다. 첨단 소프트웨어와 알고리즘이 이러한 기기에 통합되어 진단 정확도가 향상되고 인적 오류를 줄이며 검사 결과의 신뢰성이 전반적으로 향상되었습니다. 대부분의 최신 분석기에는 헤모글로빈 농도 이상이나 혈액 샘플의 잠재적 문제를 임상의에게 경고하는 플래그 시스템도 내장되어 있어 중요한 상태를 조기에 정확하게 감지할 수 있습니다.

비침습적 헤모글로빈 검사는 큰 잠재력을 가진 또 하나의 새로운 기술입니다. 기존의 헤모글로빈 검사는 바늘이나 손가락으로 혈액 샘플을 채취해야 하기 때문에 환자에게 불편함을 주었습니다. 하지만 채혈 없이도 헤모글로빈 농도를 측정할 수 있는 새로운 광학 기술과 센서를 이용한 기술이 개발되고 있습니다. 빛의 파장과 맥박 산소 측정 기술을 이용한 장치는 피부를 통해 헤모글로빈 농도를 추정할 수 있으며, 특히 수술실이나 중환자실과 같은 환경에서 지속적인 모니터링을 위한 고통스럽지 않고 편리한 대안을 제공합니다. 이러한 기술적 진보를 통해 헤모글로빈 검사는 높은 진단 정확도를 유지하면서 보다 환자 친화적이고, 보다 쉽게 이용할 수 있게 되었습니다.

헤모글로빈 검사가 건강 관리에 중요한 이유는 무엇인가?

헤모글로빈 검사는 건강 관리에 매우 중요합니다. 헤모글로빈 검사는 전신 건강과 활력에 중요한 기능인 전신 산소 운반 능력에 대한 중요한 정보를 제공하기 때문입니다. 빈혈과 같은 증상이 있는 사람들에게 정기적인 헤모글로빈 검사는 질병의 진행과 치료 효과를 모니터링하는 데 도움이 됩니다. 헤모글로빈 수치가 낮으면 피로감, 쇠약감, 호흡곤란 등의 증상이 나타나 삶의 질에 심각한 영향을 미칠 수 있습니다. 정기적인 검사를 통해 헤모글로빈 수치 감소의 원인을 파악함으로써 의료진은 영양 부족, 만성질환 또는 기타 질환 등 근본적인 문제를 치료할 수 있습니다.

화학요법이나 투석과 같은 특정 치료를 받고 있는 환자들에게 헤모글로빈 검사는 치료 관리를 위한 일상적인 요소입니다. 예를 들어, 항암화학요법은 부작용으로 빈혈을 유발하여 헤모글로빈 수치를 위험할 정도로 낮게 만들 수 있습니다. 정기적인 모니터링을 통해 의료진은 수혈이나 적혈구 생성을 촉진하는 약물 치료와 같은 치료에 신속하게 개입할 수 있습니다. 마찬가지로 만성 신장 질환 환자는 신장이 적혈구 생성을 자극하는 호르몬인 에리트로포이에틴을 충분히 생산하지 못해 빈혈이 발생하는 경우가 많습니다. 이러한 환자의 헤모글로빈 검사는 적혈구 조혈자극제(ESA)나 철분 보충제 등의 약물의 적절한 사용을 유도하는 데 도움이 됩니다.

수술 장면에서 헤모글로빈 검사는 수술 전과 수술 후 모두 필수적입니다. 수술 전 헤모글로빈 검사는 환자가 수술 스트레스를 견딜 수 있는 충분한 적혈구를 가지고 있는지 확인하고, 수술 후 검사는 출혈이나 합병증 징후가 없는지 모니터링합니다. 헤모글로빈 수치는 빈혈이 산모와 태아에게 위험을 초래할 수 있는 임신 중에도 중요합니다. 임산부 건강검진에서 정기적인 검사를 통해 임산부가 건강한 헤모글로빈 수치를 유지하여 조산이나 저체중아 출산과 같은 합병증 위험을 줄일 수 있습니다. 헤모글로빈 검사는 이러한 다양한 의료 현장에서 더 나은 건강 상태를 지원하는 중요한 데이터를 제공하며, 급성 및 만성질환 관리에 필수적인 도구가 되고 있습니다.

헤모글로빈 검사 시장의 성장을 촉진하는 요인은 무엇인가?

헤모글로빈 검사 시장의 성장은 빈혈 및 만성질환의 유병률 증가, 검사 기술의 발전, 현장 진단 의약품에 대한 수요 증가 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 빈혈, 당뇨병, 만성 신장 질환, 암 등 정기적인 헤모글로빈 모니터링이 필요한 질병이 전 세계적으로 증가하고 있다는 점입니다. 세계보건기구(WHO)에 따르면, 빈혈만 해도 전 세계 16억 명 이상이 앓고 있으며, 이 광범위한 증상을 관리하기 위해 빈번한 검사가 필요합니다. 전 세계 인구가 고령화되고 만성질환의 부담이 증가함에 따라 신뢰할 수 있고 효율적인 헤모글로빈 검사에 대한 수요는 지속적으로 증가하고 있습니다.

기술 발전, 특히 현장 검사(Point-of-Care)는 시장 성장을 촉진하는 또 다른 중요한 요소입니다. 현장 진료 헤모글로빈 검사 기기는 편리성, 휴대성, 빠른 결과로 인해 임상과 가정 모두에서 보편화되고 있습니다. 이러한 기기는 헤모글로빈 수치를 실시간으로 모니터링할 수 있기 때문에 의료진이 보다 신속하고 정보에 입각한 치료 결정을 내릴 수 있도록 돕습니다. 특히 COVID-19 팬데믹을 계기로 원격의료와 재택의료가 확산됨에 따라 POC 헤모글로빈 검사와 같이 사용하기 쉽고 접근하기 쉬운 진단 도구에 대한 수요가 증가하고 있습니다.

비침습적 헤모글로빈 검사 기술도 시장 확대에 기여하고 있습니다. 기존의 헤모글로빈 검사는 채혈이 필요했지만, 빛 기반 기술을 사용하여 헤모글로빈 수치를 추정하는 비침습적 장치는 환자에게 보다 편안하고 편리한 옵션을 제공합니다. 이러한 기술 혁신은 소아과, 응급의료, 수술 환경 등에서 특히 매력적이며, 불편함을 줄이고 검사를 간소화하여 환자 경험과 결과를 개선할 수 있습니다. 이러한 기술이 더욱 정교해지고 널리 채택됨에 따라 헤모글로빈 검사 시장의 점유율이 확대될 것으로 예상됩니다.

맞춤형 의료에 대한 수요 증가도 헤모글로빈 검사의 성장을 촉진하는 요인 중 하나입니다. 헬스케어가 개별 환자 데이터에 기반한 맞춤형 치료 계획으로 전환함에 따라, 헤모글로빈과 같은 주요 바이오마커의 빈번하고 정확한 모니터링이 필수적입니다. 예를 들어, 화학요법이나 투석 등의 치료를 받는 환자의 경우, 투약량이나 수혈 스케줄을 개별적으로 조정하기 위해 헤모글로빈의 실시간 수치에 의존하는 경우가 많습니다. 이러한 추세는 환자별 상세 데이터를 빠르고 효율적으로 제공할 수 있는 보다 정교한 헤모글로빈 검사 솔루션의 개발을 촉진하고 있습니다.

마지막으로, 빈혈 및 기타 혈액 질환을 퇴치하기 위한 정부의 노력과 공중 보건 캠페인도 시장 성장을 촉진하고 있습니다. 많은 국가에서 빈혈은 특히 임산부와 소아에서 여전히 중요한 공중 보건 문제로 남아 있습니다. 인식 제고, 진단율 향상, 치료 접근성 강화를 위한 노력은 선진국과 개발도상국을 막론하고 헤모글로빈 검사의 활용도를 높이고 있습니다. 전 세계 의료 시스템이 진단 능력을 향상시키고 만성질환을 보다 효과적으로 관리하기 위해 노력함에 따라, 신뢰할 수 있고 접근성이 높은 헤모글로빈 검사에 대한 수요는 지속적으로 증가할 것으로 예상되며, 이는 세계 진단 의약품 시장에서 중요한 성장 분야가 될 것으로 예상됩니다.

부문

컴포넌트(시약 및 소모품, 기기), 최종사용처(병원, 진단연구소, 기타 최종사용처)

조사 대상 기업 사례(주목 44개사)

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.02.21

Global Hemoglobin Testing Market to Reach US$3.9 Billion by 2030

The global market for Hemoglobin Testing estimated at US$2.8 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Hemoglobin Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Hemoglobin Testing Equipment segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$742.1 Million While China is Forecast to Grow at 8.2% CAGR

The Hemoglobin Testing market in the U.S. is estimated at US$742.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$885.7 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Hemoglobin Testing Market - Key Trends and Drivers Summarized

Is Hemoglobin Testing the Cornerstone of Diagnosing Blood Disorders?

Hemoglobin testing plays a vital role in modern healthcare, offering key insights into a patient’s blood health and overall well-being. But why is this testing so essential? Hemoglobin is a protein in red blood cells that carries oxygen from the lungs to the rest of the body. By measuring the levels of hemoglobin in the blood, healthcare providers can assess a person’s oxygen-carrying capacity and detect potential health issues such as anemia, blood loss, or other underlying conditions. Hemoglobin testing is one of the most common diagnostic tools, used in routine checkups, pre-surgical evaluations, and managing chronic diseases.

Hemoglobin levels are critical indicators of various health conditions. Low hemoglobin levels often point to anemia, a condition in which the body doesn’t have enough healthy red blood cells to transport oxygen efficiently. Anemia can be caused by factors ranging from nutritional deficiencies (like iron, vitamin B12, or folate) to chronic diseases such as kidney disease or cancer. Conversely, high hemoglobin levels can indicate conditions such as polycythemia or dehydration. Regular hemoglobin testing is therefore essential not only for diagnosing specific blood disorders but also for monitoring overall health and guiding treatment plans for individuals with chronic conditions.

How Has Technology Transformed Hemoglobin Testing?

Technological advancements have revolutionized hemoglobin testing, making it faster, more accurate, and accessible in a variety of settings. One of the most significant innovations is the development of point-of-care testing (POCT) devices, which allow for hemoglobin levels to be measured outside of traditional laboratories, in clinics, or even at home. These portable devices provide nearly instant results, helping healthcare providers make quicker diagnostic decisions, especially in emergency or remote settings where access to full laboratory services might be limited. This real-time data is particularly valuable in managing conditions like anemia or monitoring blood health during treatments such as chemotherapy or dialysis.

Automated hematology analyzers represent another major advancement in hemoglobin testing. These machines can process multiple blood parameters, including hemoglobin concentration, in just a few minutes with high precision. The integration of advanced software and algorithms into these devices has enhanced their diagnostic accuracy, reducing human error and improving the overall reliability of test results. Many modern analyzers also incorporate flagging systems that alert clinicians to abnormal hemoglobin levels or potential issues with the blood sample, ensuring that critical conditions are detected early and accurately.

Non-invasive hemoglobin testing is another emerging technology that holds great promise. Traditional hemoglobin tests require a blood sample drawn through a needle or fingerstick, which can be uncomfortable for patients. However, new optical and sensor-based technologies are being developed to measure hemoglobin levels without the need for a blood sample. Devices using light wavelengths and pulse oximetry techniques can estimate hemoglobin levels through the skin, providing a painless, convenient option for continuous monitoring, particularly in settings such as operating rooms or intensive care units. These technological advancements are making hemoglobin testing more patient-friendly and accessible while maintaining high levels of diagnostic accuracy.

Why Is Hemoglobin Testing Critical for Managing Health?

Hemoglobin testing is crucial for managing health because it provides essential information about a person’s ability to transport oxygen throughout their body, a key function for overall health and vitality. For individuals with conditions like anemia, regular hemoglobin testing helps monitor disease progression and the effectiveness of treatments. Low hemoglobin levels can lead to fatigue, weakness, and shortness of breath, symptoms that can severely impact quality of life. Identifying the cause of low hemoglobin through routine testing allows healthcare providers to treat the underlying issue, whether it’s a nutritional deficiency, chronic disease, or another condition.

For patients undergoing certain treatments, such as chemotherapy or dialysis, hemoglobin testing is a routine part of managing care. In cancer treatment, for instance, chemotherapy can cause anemia as a side effect, leading to dangerously low hemoglobin levels. Regular monitoring ensures that healthcare providers can intervene promptly with treatments like blood transfusions or medication to boost red blood cell production. Similarly, patients with chronic kidney disease often experience anemia because their kidneys are not producing enough erythropoietin, a hormone that stimulates red blood cell production. Hemoglobin testing in these patients helps guide the appropriate use of medications like erythropoiesis-stimulating agents (ESAs) and iron supplements.

In surgical settings, hemoglobin testing is essential both before and after procedures. Pre-surgical hemoglobin testing ensures that a patient has sufficient red blood cells to withstand the stress of surgery, while post-surgical testing monitors for signs of blood loss or complications. Hemoglobin levels are also important in pregnancy, where anemia can pose risks to both the mother and baby. Regular testing during prenatal care helps ensure that pregnant women maintain healthy hemoglobin levels, reducing the risk of complications like preterm birth or low birth weight. Across these various healthcare scenarios, hemoglobin testing provides critical data that supports better health outcomes, making it an indispensable tool in managing both acute and chronic conditions.

What Factors Are Driving the Growth of the Hemoglobin Testing Market?

The growth of the hemoglobin testing market is driven by several key factors, including the rising prevalence of anemia and chronic diseases, advancements in testing technology, and increasing demand for point-of-care diagnostics. One of the primary drivers is the global rise in conditions like anemia, diabetes, chronic kidney disease, and cancer, which require regular hemoglobin monitoring. Anemia alone affects over 1.6 billion people worldwide, according to the World Health Organization (WHO), driving the need for frequent testing to manage this widespread condition. As the global population ages and the burden of chronic disease grows, the demand for reliable, efficient hemoglobin testing continues to increase.

Technological advancements, particularly in point-of-care testing, are another significant factor propelling market growth. Point-of-care hemoglobin testing devices are becoming more common in both clinical and home settings due to their convenience, portability, and rapid results. These devices allow for real-time monitoring of hemoglobin levels, helping healthcare providers make faster, more informed treatment decisions. As telemedicine and at-home healthcare gain traction, especially in light of the COVID-19 pandemic, the demand for easy-to-use, accessible diagnostic tools like point-of-care hemoglobin tests is on the rise.

Non-invasive hemoglobin testing technologies are also contributing to market expansion. While traditional hemoglobin testing requires blood samples, non-invasive devices that use light-based technologies to estimate hemoglobin levels offer a more comfortable and convenient option for patients. These innovations are particularly appealing in settings like pediatrics, emergency care, and surgical environments, where reducing discomfort and streamlining testing can lead to better patient experiences and outcomes. As these technologies become more refined and widely adopted, they are expected to capture a growing share of the hemoglobin testing market.

The rising demand for personalized medicine is another factor fueling the growth of hemoglobin testing. As healthcare moves towards more tailored treatment plans based on individual patient data, frequent and accurate monitoring of key biomarkers like hemoglobin is essential. For instance, in patients receiving treatments like chemotherapy or dialysis, personalized adjustments to medication dosages or transfusion schedules often depend on real-time hemoglobin levels. This trend is pushing the development of more sophisticated hemoglobin testing solutions that can deliver detailed, patient-specific data quickly and efficiently.

Lastly, government initiatives and public health campaigns aimed at combating anemia and other blood disorders are also driving market growth. In many countries, anemia remains a significant public health issue, particularly in pregnant women and children. Efforts to increase awareness, improve diagnosis rates, and enhance access to treatment are leading to greater utilization of hemoglobin testing in both developed and developing regions. As healthcare systems around the world focus on improving diagnostic capabilities and managing chronic diseases more effectively, the demand for reliable and accessible hemoglobin testing is expected to continue rising, making it a key growth area in the global diagnostics market.

SCOPE OF STUDY:

The report analyzes the Hemoglobin Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents & Consumables, Equipment); End-Use (Hospitals, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Hemoglobin Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Anemia and Blood Disorders Propels Demand for Hemoglobin Testing Solutions
    • Role of Hemoglobin Testing in Supporting Routine Health Checkups and Chronic Disease Management
    • Growth in Demand for Anemia Testing in Pregnant Women and Pediatric Populations Drives Adoption
    • Expansion of Hemoglobin Testing Solutions in Blood Banks and Transfusion Centers Fuels Market Growth
    • Growth in Demand for Hemoglobin A1c Testing for Diabetes Management Expands Addressable Market
    • Role of Hemoglobin Testing in Supporting Blood Donation and Safe Transfusion Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemoglobin Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Hemoglobin Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hemoglobin Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Hemoglobin Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Hemoglobin Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제